Skip to content

Clinical trials

Insulin Resistance trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Country / region: Mexico Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20071
20082
20091
20101
20111
20123
20133
20146
20155
20164
20173
20184
201911
20213
20222
20233
20244
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Unknown status10
Active, not recruiting3
Recruiting3
Terminated3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Guadalajara18
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran7
Coordinación de Investigación en Salud, Mexico6
Universidad de Guanajuato5
Eli Lilly and Company3
Centro Universitario de Ciencias de la Salud, Mexico2
Hospital Central "Dr. Ignacio Morones Prieto"2
Hospital General de México Dr. Eduardo Liceaga2
AstraZeneca1
Hospital Infantil de Mexico Federico Gomez1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance63
Metabolic Syndrome15
Diabetes Mellitus, Type 212
Obesity12
Diabetes Mellitus9
Prediabetic State8
Glucose Intolerance6
Hyperglycemia3
Obesity, Abdominal3
Pediatric Obesity3

Trials

Showing 76 to 63 of 63. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.